Comprehensive analysis of R-spondin fusions and RNF43 mutations implicate novel therapeutic options in colorectal cancer. Seeber A, Battaglin F, Zimmer K, Kocher F, et al. Clin Cancer Res 2022 Mar 7. pii: 681556. doi: 10.1158/1078-0432.CCR-21-3018.

Read + Share

Amedeo Smart

Independent Medical Education

Seeber A, Battaglin F, Zimmer K, Kocher F, et al. Comprehensive analysis of R-spondin fusions and RNF43 mutations implicate novel therapeutic options in colorectal cancer. Clin Cancer Res 2022 Mar 7. pii: 681556. doi: 10.1158/1078-0432.CCR-21-3018.
PMID: 35254413